Literature DB >> 1538709

Heterogeneity of angiotensin II AT2 receptors in the rat brain.

K Tsutsumi1, J M Saavedra.   

Abstract

Angiotensin II (AT) receptor subtypes (AT1, selectively displaced by DuP 753, and AT2, selectively displaced by PD123177 and CGP42112A) were characterized by quantitative autoradiography after incubation with the AT agonist 125I-Sar1-AT, in specific brain nuclei of young (2-week-old) rats. Binding to AT1 receptors was sensitive (decreased affinity) to incubation in the presence of guanosine 5'-O-(3-thio)triphosphate (GTP gamma S). Only the AT1 receptors in the paraventricular nucleus were sensitive to pertussis toxin, indicating the possibility of the existence of AT1 receptor subtypes. The sensitivity of AT2 receptors to GTP gamma S was heterogeneous. In the ventral thalamic and medial geniculate nuclei and in the locus coeruleus, binding to AT2 receptors was sensitive to GTP gamma S and to pertussis toxin pretreatment. Conversely, in the inferior olive, binding was insensitive to GTP gamma S and to pertussis toxin pretreatment. We propose the nomenclature of AT2A receptors for those receptors sensitive to guanine nucleotides and pertussis toxin and that of AT2B receptors for those showing no sensitivity to guanine nucleotides or pertussis toxin treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538709

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions.

Authors:  Z Salamon; S Cowell; E Varga; H I Yamamura; V J Hruby; G Tollin
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

2.  Pharmacological characterization of angiotensin II AT(2) receptor subtype heterogeneity in the rat adrenal cortex and medulla.

Authors:  X Lu; K L Grove; W Zhang; R C Speth
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

Review 3.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

4.  Characterization of AT2 receptor expression in NIH 3T3 fibroblasts.

Authors:  F M Heemskerk; S Zorad; N Xu; S J Gutkind; J M Saavedra
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

5.  Functional diversity of AT2 receptor orthologues in closely related species.

Authors:  Ying-Hong Feng; Lingyin Zhou; Yan Sun; Janice G Douglas
Journal:  Kidney Int       Date:  2005-05       Impact factor: 10.612

6.  Biphasic effects of suramin on 125I-epidermal growth factor binding to human meningiomas.

Authors:  K Tsutsumi; N Kitagawa; M Niwa; S Yamaga; H Khalid; K Taniyama; A Himeno; S Shibata
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046

7.  Endothelin receptor in microvessels isolated from human meningiomas: quantification with radioluminography.

Authors:  S Yamaga; K Tsutsumi; M Niwa; N Kitagawa; T Anda; A Himeno; H Khalid; K Taniyama; S Shibata
Journal:  Cell Mol Neurobiol       Date:  1995-06       Impact factor: 5.046

8.  Development of polyclonal antibodies against angiotensin type 2 receptors.

Authors:  L P Reagan; M Theveniau; X D Yang; I R Siemens; D K Yee; T Reisine; S J Fluharty
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

9.  A selective endothelin ETA antagonist, BQ-123, inhibits 125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells.

Authors:  N Kitagawa; K Tsutsumi; M Niwa; S Yamaga; T Anda; H Khalid; A Himeno; K Taniyama; S Shibata
Journal:  Cell Mol Neurobiol       Date:  1994-04       Impact factor: 5.046

10.  Angiotensin II AT2 receptors are functionally coupled to protein tyrosine dephosphorylation in N1E-115 neuroblastoma cells.

Authors:  C Nahmias; S M Cazaubon; M M Briend-Sutren; D Lazard; P Villageois; A D Strosberg
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.